AGL
AGILON HEALTH (AGL)
NYSE
$81.00-$5.75 (-6.63%)
Price as of Jun 03, 2026 6:43 PM EDT
  • $1.5B
    Market Cap
  • 52.86%
    1-Year Change
  • Medical Care Facilities
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
5.9B
-2.30%
6.1B
+40.41%
4.3B
N/A
Cost of Revenue
6.0B
-23.57%
7.8B
+45.48%
5.4B
N/A
Gross Profit
-56.6M
-96.79%
-1.8B
+66.13%
-1.1B
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
28.6M
+16.89%
24.5M
+21.34%
20.2M
N/A
Total Operating Expenses
6.4B
+0.68%
6.4B
+39.67%
4.5B
N/A
Operating Profit
-463.2M
+58.57%
-292.1M
+25.85%
-232.1M
N/A
Interest Income
458,000
-23.15%
596,000
-6.44%
637,000
N/A
Interest Expense
N/A
N/A
N/A
N/A
-6.7M
N/A
Interest Income and Expense and Net
458,000
-23.15%
596,000
+109.90%
-6.0M
N/A
Total Nonoperating Income and Expense
67.6M
+96.05%
34.5M
+23.88%
27.8M
N/A
Income before Taxes
-404.1M
+62.40%
-248.8M
+27.96%
-194.5M
N/A
Income Taxes
1.3M
-13.78%
1.5M
+83.44%
791,000
N/A
Extraordinary Items
36.1M
+903.48%
3.6M
N/A
N/A
N/A
Net Income
-391.3M
+50.43%
-260.2M
-0.93%
-262.6M
N/A
Net Income from Continuing Operations Applicable to Common
-404.1M
+62.40%
-248.8M
+27.96%
-194.5M
N/A
Basic EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
414.0M
+0.73%
411.0M
+0.50%
408.9M
N/A
Diluted Weighted Average Shares
414.0M
+0.73%
411.0M
+0.50%
408.9M
N/A
Balance Sheet
Cash and Cash Equivalents
173.7M
-7.71%
188.2M
+74.98%
107.6M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
173.7M
-7.71%
188.2M
+74.98%
107.6M
N/A
Total Current Assets
1.1B
-24.77%
1.5B
-1.51%
1.5B
N/A
Accumulated Depreciation
3.3M
-86.63%
24.7M
+72.34%
14.3M
N/A
Property and Plant and Equipment and Net
25.4M
-9.77%
28.2M
+2.15%
27.6M
N/A
Total Long-Term Assets
83.5M
-44.78%
151.1M
+4.01%
145.3M
N/A
Total Assets
1.3B
-26.68%
1.7B
-0.40%
1.7B
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
19.2M
N/A
N/A
N/A
6.3M
N/A
Total Current Liabilities
1.1B
-6.56%
1.2B
+17.89%
977.2M
N/A
Total Long-Term Debt
15.8M
-54.88%
34.9M
+8.04%
32.3M
N/A
Total Long-Term Liabilities
52.3M
-31.27%
76.1M
+8.16%
70.4M
N/A
Total Liabilities
1.1B
-9.38%
1.3B
+16.96%
1.1B
N/A
Retained Earnings
-2.0B
+24.66%
-1.6B
+19.61%
-1.3B
N/A
Total Stockholders Equity
126.7M
-73.09%
471.0M
-28.84%
661.8M
N/A
Total Shares Outstanding
414.7M
+0.61%
412.2M
+1.43%
406.4M
N/A
Cash Flow
Cash from Operating Activities
-105.8M
+83.05%
-57.8M
-63.01%
-156.2M
N/A
Capital Expenditures
13.2M
-0.07%
13.3M
-16.29%
15.8M
N/A
Cash from Investing Activities
88.6M
-36.66%
139.9M
+417.80%
-44.0M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-3.0M
+15.91%
-2.6M
-98.66%
-193.1M
N/A
Financials Ratio
Gross Margin
-0.96%
-96.71%
-29.05%
N/A
N/A
N/A
Operating Margin
-7.82%
+62.30%
-4.82%
N/A
N/A
N/A
Return on Assets
-26.04%
+73.94%
-14.97%
N/A
N/A
N/A
Return on Equity
-130.95%
+185.11%
-45.93%
N/A
N/A
N/A
Revenue Growth
-2.30%
-105.68%
40.41%
N/A
N/A
N/A
Current Ratio
1.02
-19.49%
1.27
N/A
N/A
N/A
Cash Ratio
0.16
-1.22%
0.16
N/A
N/A
N/A
Debt-to-Equity Ratio
0.28
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.03
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow